First trading day of June, Dow set to rise, third straight up month?

This is a live blog. Check back for updates.

Shares of Pfizer slipped more than 5{3c4481f38fc19dde56b7b1f4329b509c88239ba5565146922180ec5012de023f} during premarket trading after the company reported disappointing results from its breast cancer drug trial. “The trial is unlikely to show a statistically significant improvement in the primary endpoint of invasive disease-free survival,” a release from the company said. “We are disappointed in this outcome,” said Chris Boshoff, Pfizer global product development’s chief development officer in the oncology division. Shares of the pharma giant are down roughly 2{3c4481f38fc19dde56b7b1f4329b509c88239ba5565146922180ec5012de023f} this year. – Stevens

Stocks were set to kick off the month little changed, with futures pointing to modest gains at the open for the S&P 500 and Dow Jones Industrial Average, while the Nasdaq Composite was slated to open slightly lower. All major averages are coming off a positive week — it was the Dow’s best week since early April — as well as their second straight positive month. Stocks have moved higher as states around the country have begun to reopen their economies. But widespread protests over the weekend have sparked fears that there could be a second wave of coronavirus cases. – Stevens 

Subscribe to CNBC PRO for exclusive insights and analysis, and live business day programming from around the world.